Marshall Wace
ARNA

Marshall Wace’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Marshall Wace’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-39,846
Closed -$3.71M – 4355
2021
Q4 		$3.71M Buy
+39,846
New +$2.63M 0.01% 1604
2021
Q1 		– Sell
-6,102
Closed -$469K – 3023
2020
Q4 		$469K Sell
6,102
-797
-12% -$59.7K ﹤0.01% 1481
2020
Q3 		$516K Sell
6,899
-25,546
-79% -$1.7M ﹤0.01% 1235
2020
Q2 		$2.04M Buy
+32,445
New +$1.79M 0.01% 785
2020
Q1 		– Sell
-228,307
Closed -$10.4M – 2219
2019
Q4 		$10.4M Sell
228,307
-22,745
-9% -$1.08M 0.07% 309
2019
Q3 		$11.5M Buy
251,052
+223,001
+795% +$12.5M 0.09% 262
2019
Q2 		$1.64M Buy
28,051
+23,101
+467% +$1.19M 0.01% 823
2019
Q1 		$222K Sell
4,950
-79,737
-94% -$3.66M ﹤0.01% 1318
2018
Q4 		$3.3M Buy
+84,687
New +$3.33M 0.03% 590
2018
Q3 		– Sell
-6,816
Closed -$297K – 1323
2018
Q2 		$297K Buy
6,816
+1,278
+23% +$54.9K ﹤0.01% 632
2018
Q1 		$219K Buy
+5,538
New +$215K 0.01% 511

Marshall Wace's ARNA Position: Q1 2022 in Review

Marshall Wace sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 39,846 shares — an estimated $3.71M sold.

Marshall Wace first reported a position in ARNA in Q1 2018 and held it in 11 quarters. The position peaked at $11.5M in Q3 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Marshall Wace reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Marshall Wace sold 39,846 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.71M.
  • Marshall Wace first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 11 quarters.
  • Marshall Wace's Arena Pharmaceuticals Inc position peaked at $11.5M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.